DEA [and FDA] OKs synthetic marijuana for pharma company that spent $500,000 to keep [the plant, marijuana] illegal
“It appears they [Insys] are trying to kill a non-pharmaceutical market for marijuana in order to line their own pockets,” a spokesman for Arizona’s marijuana legalization campaign said of Insys last year … The company [Insys] last year said that it opposed the marijuana legalization measure because “it fails to protect the safety of Arizona’s citizens, and particularly its children.”
Insys gave $500,000 last summer to Arizonans for Responsible Drug Policy, the group opposing marijuana legalization in Arizona. The donation amounted to roughly 10 percent of all money raised by the group in an ultimately successful campaign against legalization. Insys was the only pharmaceutical company known to be giving money to oppose legalization last year … Insys is also the subject of numerous state and federal criminal investigations, as well as a shareholder lawsuit, over its aggressive marketing of a product containing the potent and deadly opioid painkiller fentanyl. In December, the FBI arrested the company’s former chief executive and five other executives on charges that they “paid kickbacks and committed fraud to sell a highly potent and addictive opioid that can lead to abuse and life threatening respiratory depression.” In addition to its synthetic marijuana products, Insys is also developing a drug to treat opioid overdose.
Original Article (Chicago Tribune):
DEA OKs synthetic marijuana for pharma company that spent $500,000 to keep [the plant, marijuana] illegal
Artwork Fair Use: almogaver